Navigation Links
James Thomson plans to stay in Madison to study genesis of stem cells

Professor James Thomson studies stem cells in his Primate Center lab. Photo courtesy of the University of Wisconsin-Madison.
Madison, Wis. James Thomson avoided talking politics in a public lecture on the eve of the presidential election, explaining instead the science behind his research......

Full article >>> f Caspase 3/7, enzymes that break down proteins as part of a process called programmed cell death, in which unneeded cells are culled during normal development of the body. Yet the stem cells do not die, Thomson said, even though the Caspase levels would kill most other cells. The reason is unknown.

Once embryonic stem cells are derived in the lab and cultured, they are no longer quite li......

Full article >>>
Ever since President Bush forbade research using federal money on embryonic stem-cell cultures created after August 9, 2001, scientists have made few with a handful of existing cultures. The WiCell institute, where Thomson is scientific director, owns six. And though stem cells can theoretically keep growing forever, those cultures were made using old techniques that led to impuriti......

Full article >>>
'"/>

Source:wistechnology.com By Jason Stitt 11/01/04


Related biology technology :

1. Germantown drug company hires pharma veteran James Davidson as COO
2. State puts up $1 million for James Thomsons new stem cell startup
3. UW stem-cell team led by James Thomson gets $1.25M private grant
4. OpGen adds Thomas Pyle and James Ogle to board of directors
5. Jamie Thomson to run California research lab
6. Thomson lends perspective to stem cell expectations
7. Thomson gives a blueprint of UWs stem cell research
8. Identity theft start up has fast-track growth plans
9. CDW buyer supports Berbee growth plans
10. Whitewater makes plans for business incubator
11. Donley has growth plans for stem cell bank
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... March 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) ... immune therapies for solid tumor cancers, today announced ... financing it announced last Friday, March 17, 2017. ... institutional investors securities totaling 28,843,692 shares, comprised of ... 10,000,000 shares of Class C Warrants pre-funded at ...
(Date:3/23/2017)... , March 23, 2017 Kineta, ... development of novel therapies in immuno-oncology, today announced ... lead" small molecule compounds that activate interferon response ... pathways and demonstrate immune-mediated tumor regression in a ... the study who demonstrated complete tumor regression to ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... solutions, today announced the hire of Dr. Sigmund “Sig” Floyd as Vice President ... strategic partnerships and joint development activities. , “Dr. Floyd’s career has spanned 30 ...
(Date:3/22/2017)... , March 22, 2017 Good Start ... it has eclipsed the 130 million covered lives mark ... Shield of Texas . With newly ... Company continues to enjoy strong payor acceptance based on ... clinical programs and genetic counseling, its industry-leading customer care ...
Breaking Biology Technology:
(Date:3/22/2017)... Calif. , March 21, 2017 ... analytics company serving law enforcement agencies, announced today the ... as director of public safety business development. ... diversified law enforcement experience, including a focus on the ... In his most recent position, Mr. Sheridan served as ...
(Date:3/9/2017)... , Australia , March 9, ... study data at the prestigious World Lung Imaging Workshop ... Andreas Fouras , was invited to deliver the ... pulmonary medicine. This globally recognised event brings together leaders ... share the latest developments in lung imaging. ...
(Date:3/2/2017)... March 2, 2017 Summary This report ... and its partnering interests and activities since 2010. ... Read the full ... Alliance since 2010 report provides an in-depth insight into the ... companies. On demand company reports are prepared upon ...
Breaking Biology News(10 mins):